A G protein-coupled receptor and the intracellular synthase of its agonist functionally cooperate

Journal of Cell Biology

Volumn 204, Issue 3, 2014, Pages 377-393

  Binda, Chantal ^a,c   Génier, Samuel ^a,c   Cartier, Andréane ^a,c   Larrivée, Jean François ^b,c   Stankova, Jana ^b,c   Young, Jason C ^d   Parent, Jean Luc ^a,c  

^a Service de Rhumatologie   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HEAT SHOCK PROTEIN 90; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2 SYNTHASE; SYNTHETASE; TRANSCRIPTION FACTOR DP1; UNCLASSIFIED DRUG;

AGONIST; ARTICLE; AUTOCRINE EFFECT; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CELL SURFACE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; INTRACELLULAR MEMBRANE; MEDIATOR; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

CELL MEMBRANE; CELL NUCLEUS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEK293 CELLS; HELA CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INTRACELLULAR SPACE; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MAP KINASE SIGNALING SYSTEM; MUTANT PROTEINS; PROTEIN TRANSPORT; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PROSTAGLANDIN; TRANS-GOLGI NETWORK;

EID: 84893490892     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201304015     Document Type: Article

References (64)

1. Belmonte, S.L., and B.C. Blaxall. 2011. G protein coupled receptor kinases as therapeutic targets in cardiovascular disease. Circ. Res. 109:309-319. http://dx.doi.org/10.1161/CIRCRESAHA.110.231233
2. Brinker, A., C. Scheufler, F. Von Der Mulbe, B. Fleckenstein, C. Herrmann, G. Jung, I. Moarefi, and F.U. Hartl. 2002. Ligand discrimination by TPR domains. Relevance and selectivity of EEVD-recognition in Hsp70. Hop. Hsp90 complexes. J. Biol. Chem. 277:19265-19275. http://dx.doi.org/10.1074/jbc. M109002200
3. Cartier, A., A. Parent, P. Labrecque, G. Laroche, and J.L. Parent. 2011. WDR36 acts as a scaffold protein tethering a G-protein-coupled receptor, Gαq and phospholipase Cβ in a signalling complex. J. Cell Sci. 124:3292-3304. http://dx.doi.org/10.1242/jcs.085795
4. Chen, C.Y., and W.E. Balch. 2006. The Hsp90 chaperone complex regulates GDI-dependent Rab recycling. Mol. Biol. Cell. 17:3494-3507. http://dx.doi.org/10.1091/mbc. E05-12-1096
5. Chiba, T., S. Ueki, W. Ito, H. Kato, R. Kamada, M. Takeda, H. Kayaba, M. Furue, and J. Chihara. 2011. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration. Ann. Allergy Asthma Immunol. 106:511-517. http://dx.doi.org/10.1016/j.anai.2011.01.027
6. Cliff, M.J., R. Harris, D. Barford, J.E. Ladbury, and M.A. Williams. 2006. Conformational diversity in the TPR domain-mediated interaction of protein phosphatase 5 with Hsp90. Structure. 14:415-426. http://dx.doi.org/10.1016/j.str.2005.12.009
7. Conn, P.M., A. Ulloa-Aguirre, J. Ito, and J.A. Janovick. 2007. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol. Rev. 59:225-250. http://dx.doi.org/10.1124/pr.59.3.2
8. Décaillot, F.M., R. Rozenfeld, A. Gupta, and L.A. Devi. 2008. Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. Proc. Natl. Acad. Sci. USA. 105:16045-16050. http://dx.doi.org/10.1073/pnas.0804106105
9. Durand, M., M.A. Gallant, and A.J. de Brum-Fernandes. 2008. Prostaglandin D2 receptors control osteoclastogenesis and the activity of human osteoclasts. J. Bone Miner. Res. 23:1097-1105. http://dx.doi.org/10.1359/jbmr.080228
10. Filipeanu, C.M., R. de Vries, A.H. Danser, and D.R. Kapusta. 2011. Modulation of α(2C) adrenergic receptor temperature-sensitive trafficking by HSP90. Biochim. Biophys. Acta. 1813:346-357. http://dx.doi.org/10.1016/j.bbamcr.2010.11.020
11. Fujimori, K., Y. Kanaoka, Y. Sakaguchi, and Y. Urade. 2000. Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the oct-1 element in the 5'-flanking region and the AP-2 element in the untranslated exon 1. J. Biol. Chem. 275:40511-40516. http://dx.doi.org/10.1074/jbc. M007688200
12. Gallant, M.A., R. Samadfam, J.A. Hackett, J. Antoniou, J.L. Parent, and A.J. de Brum-Fernandes. 2005. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. J. Bone Miner. Res. 20:672-681. http://dx.doi.org/10.1359/JBMR.041211
13. Gallant, M.A., D. Slipetz, E. Hamelin, M.D. Rochdi, S. Talbot, A.J. de Brum-Fernandes, and J.L. Parent. 2007. Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2. Eur. J. Pharmacol. 557:115-123. http://dx.doi.org/10.1016/j.ejphar.2006.11.058
14. García-Cardeña, G., R. Fan, V. Shah, R. Sorrentino, G. Cirino, A. Papapetropoulos, and W.C. Sessa. 1998. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 392:821-824. http://dx.doi.org/10.1038/33934
15. Gazda, L., W. Pokrzywa, D. Hellerschmied, T. Löwe, I. Forné, F. Mueller-Planitz, T. Hoppe, and T. Clausen. 2013. The myosin chaperone UNC-45 is organized in tandem modules to support myofilament formation in C. elegans. Cell. 152:183-195. http://dx.doi.org/10.1016/j.cell.2012.12.025
16. Gorska, M., U. Popowska, A. Sielicka-Dudzin, A. Kuban-Jankowska, W. Sawczuk, N. Knap, G. Cicero, and F. Wozniak. 2012. Geldanamycin and its derivatives as Hsp90 inhibitors. Front Biosci (Landmark Ed). 17:2269-2277. http://dx.doi.org/10.2741/4050
17. Hartl, F.U., A. Bracher, and M. Hayer-Hartl. 2011. Molecular chaperones in protein folding and proteostasis. Nature. 475:324-332. http://dx.doi.org/10.1038/nature10317
18. He, F., Z.H. Qiao, J. Cai, W. Pierce, D.C. He, and Z.H. Song. 2007. Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor. Mol. Pharmacol. 72:1289-1300. http://dx.doi.org/10.1124/mol.107.036566
19. Hirata, T., and S. Narumiya. 2012. Prostanoids as regulators of innate and adaptive immunity. Adv. Immunol. 116:143-174. http://dx.doi.org/10.1016/B978-0-12-394300-2.00005-3
20. Hohwy, M., L. Spadola, B. Lundquist, P. Hawtin, J. Dahmén, I. Groth-Clausen, E. Nilsson, S. Persdotter, K. von Wachenfeldt, R.H. Folmer, and K. Edman. 2008. Novel prostaglandin D synthase inhibitors generated by fragmentbased drug design. J. Med. Chem. 51:2178-2186. http://dx.doi.org/10.1021/jm701509k
21. Imai, J., H. Yashiroda, M. Maruya, I. Yahara, and K. Tanaka. 2003. Proteasomes and molecular chaperones: cellular machinery responsible for folding and destruction of unfolded proteins. Cell Cycle. 2:584-590. http://dx.doi.org/10.4161/cc.2.6.586
22. Jackson, S.E. 2013. Hsp90: structure and function. Top. Curr. Chem. 328: 155-240. http://dx.doi.org/10.1007/128_2012_356
23. Kanekiyo, T., T. Ban, K. Aritake, Z.L. Huang, W.M. Qu, I. Okazaki, I. Mohri, S. Murayama, K. Ozono, M. Taniike, et al. 2007. Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Proc. Natl. Acad. Sci. USA. 104:6412-6417. http://dx.doi.org/10.1073/pnas.0701585104
24. Kriegenburg, F., L. Ellgaard, and R. Hartmann-Petersen. 2012. Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation. FEBS J. 279:532-542. http://dx.doi.org/10.1111/j.1742-4658.2011.08456.x
25. Kumasaka, T., K. Aritake, H. Ago, D. Irikura, T. Tsurumura, M. Yamamoto, M. Miyano, Y. Urade, and O. Hayaishi. 2009. Structural basis of the catalytic mechanism operating in open-closed conformers of lipocalin type prostaglandin D synthase. J. Biol. Chem. 284:22344-22352. http://dx.doi.org/10.1074/jbc. M109.018341
26. Labrecque, P., S.J. Roy, L. Fréchette, C. Iorio-Morin, M.A. Gallant, and J.L. Parent. 2013. Inverse agonist and pharmacochaperone properties of MK-0524 on the prostanoid DP1 receptor. PLoS ONE. 8:e65767. http://dx.doi.org/10.1371/journal.pone.0065767
27. Lachance, V., A. Cartier, S. Génier, S. Munger, P. Germain, P. Labrecque, and J.L. Parent. 2011. Regulation of β2-adrenergic receptor maturation and anterograde trafficking by an interaction with Rab geranylgeranyltransferase: modulation of Rab geranylgeranylation by the receptor. J. Biol. Chem. 286:40802-40813. http://dx.doi.org/10.1074/jbc. M111.267815
28. Lappano, R., and M. Maggiolini. 2012. GPCRs and cancer. Acta Pharmacol. Sin. 33:351-362. http://dx.doi.org/10.1038/aps.2011.183
29. Lebon, G., and C.G. Tate. 2012. G protein-coupled receptors in the spotlight. [In French.] Med. Sci. (Paris). 28:876-882. http://dx.doi.org/10.1051/medsci/20122810017
30. Leskelä, T.T., P.M. Markkanen, E.M. Pietilä, J.T. Tuusa, and U.E. Petäjä-Repo. 2007. Opioid receptor pharmacological chaperones act by binding and stabilizing newly synthesized receptors in the endoplasmic reticulum. J. Biol. Chem. 282:23171-23183. http://dx.doi.org/10.1074/jbc. M610896200
31. Luo, J., and J.L. Benovic. 2003. G protein-coupled receptor kinase interaction with Hsp90 mediates kinase maturation. J. Biol. Chem. 278:50908-50914. http://dx.doi.org/10.1074/jbc. M307637200
32. Magalhaes, A.C., H. Dunn, and S.S. Ferguson. 2012. Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins. Br. J. Pharmacol. 165:1717-1736. http://dx.doi.org/10.1111/j.1476-5381.2011.01552.x
33. Mathurin, K., M.A. Gallant, P. Germain, H. Allard-Chamard, J. Brisson, C. Iorio-Morin, A. de Brum Fernandes, M.G. Caron, S.A. Laporte, and J.L. Parent. 2011. An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production. J. Biol. Chem. 286:2696-2706. http://dx.doi.org/10.1074/jbc. M110.178277
34. McClellan, A.J., Y. Xia, A.M. Deutschbauer, R.W. Davis, M. Gerstein, and J. Frydman. 2007. Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches. Cell. 131:121-135. http://dx.doi.org/10.1016/j.cell.2007.07.036
35. Miyamoto, Y., S. Nishimura, K. Inoue, S. Shimamoto, T. Yoshida, A. Fukuhara, M. Yamada, Y. Urade, N. Yagi, T. Ohkubo, and T. Inui. 2010. Structural analysis of lipocalin-type prostaglandin D synthase complexed with biliverdin by small-angle X-ray scattering and multi-dimensional NMR. J. Struct. Biol. 169:209-218. http://dx.doi.org/10.1016/j.jsb.2009.10.005
36. Morita, I., M. Schindler, M.K. Regier, J.C. Otto, T. Hori, D.L. DeWitt, and W.L. Smith. 1995. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J. Biol. Chem. 270:10902-10908. http://dx.doi.org/10.1074/jbc.270.18.10902
37. Narumiya, S., Y. Sugimoto, and F. Ushikubi. 1999. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:1193-1226.
38. Oguma, T., K. Asano, and A. Ishizaka. 2008. Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma. Allergol. Int. 57:307-312. http://dx.doi.org/10.2332/allergolint.08-RAI-0033
39. Oksche, A., R. Schülein, C. Rutz, U. Liebenhoff, J. Dickson, H. Müller, M. Birnbaumer, and W. Rosenthal. 1996. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function. Mol. Pharmacol. 50:820-828.
40. Pai, K.S., V.B. Mahajan, A. Lau, and D.D. Cunningham. 2001. Thrombin receptor signaling to cytoskeleton requires Hsp90. J. Biol. Chem. 276:32642-32647. http://dx.doi.org/10.1074/jbc. M104212200
41. Parent, A., E. Hamelin, P. Germain, and J.L. Parent. 2009. Rab11 regulates the recycling of the beta2-adrenergic receptor through a direct interaction. Biochem. J. 418:163-172. http://dx.doi.org/10.1042/BJ20080867
42. Parent, A., S.J. Roy, C. Iorio-Morin, M.C. Lépine, P. Labrecque, M.A. Gallant, D. Slipetz, and J.L. Parent. 2010. ANKRD13C acts as a molecular chaperone for G protein-coupled receptors. J. Biol. Chem. 285:40838-40851. http://dx.doi.org/10.1074/jbc. M110.142257
43. Petäjä-Repo, U.E., M. Hogue, S. Bhalla, A. Laperrière, J.P. Morello, and M. Bouvier. 2002. Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J. 21:1628-1637. http://dx.doi.org/10.1093/emboj/21.7.1628
44. Rodrigo-Brenni, M.C., and R.S. Hegde. 2012. Design principles of protein biosynthesis-coupled quality control. Dev. Cell. 23:896-907. http://dx.doi.org/10.1016/j.devcel.2012.10.012
45. Rosenbaum, E.E., K.S. Brehm, E. Vasiljevic, C.H. Liu, R.C. Hardie, and N.J. Colley. 2011. XPORT-dependent transport of TRP and rhodopsin. Neuron. 72:602-615. http://dx.doi.org/10.1016/j.neuron.2011.09.016
46. Roy, S.J., I. Glazkova, L. Fréchette, C. Iorio-Morin, C. Binda, D. Pétrin, P. Trieu, M. Robitaille, S. Angers, T.E. Hébert, and J.L. Parent. 2013. Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability. Mol. Endocrinol. 27:1245-1266. http://dx.doi.org/10.1210/me.2013-1091
47. Sakisaka, T., T. Meerlo, J. Matteson, H. Plutner, and W.E. Balch. 2002. RabalphaGDI activity is regulated by a Hsp90 chaperone complex. EMBO J. 21:6125-6135. http://dx.doi.org/10.1093/emboj/cdf603
48. Scheufler, C., A. Brinker, G. Bourenkov, S. Pegoraro, L. Moroder, H. Bartunik, F.U. Hartl, and I. Moarefi. 2000. Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine. Cell. 101:199-210. http://dx.doi.org/10.1016/S0092-8674(00)80830-2
49. Schuligoi, R., E. Sturm, P. Luschnig, V. Konya, S. Philipose, M. Sedej, M. Waldhoer, B.A. Peskar, and A. Heinemann. 2010. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases. Pharmacology. 85:372-382. http://dx.doi.org/10.1159/000313836
50. Sikorski, R.S., M.S. Boguski, M. Goebl, and P. Hieter. 1990. A repeating amino acid motif in CDC23 defines a family of proteins and a new relationship among genes required for mitosis and RNA synthesis. Cell. 60:307-317. http://dx.doi.org/10.1016/0092-8674(90)90745-Z
51. Tadevosyan, A., G. Vaniotis, B.G. Allen, T.E. Hébert, and S. Nattel. 2012. G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function. J. Physiol. 590:1313-1330.
52. Taipale, M., D.F. Jarosz, and S. Lindquist. 2010. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat. Rev. Mol. Cell Biol. 11:515-528. http://dx.doi.org/10.1038/nrm2918
53. Tanaka, K., K. Ogawa, K. Sugamura, M. Nakamura, S. Takano, and K. Nagata. 2000. Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J. Immunol. 164:2277-2280.
54. Ulloa-Aguirre, A., and P. Michael Conn. 2011. Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors. Recent Pat. Endocr. Metab, Immune Drug Discov. 5:13-24. http://dx.doi.org/10.2174/187221411794351851
55. Urade, Y., and O. Hayaishi. 2000. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim. Biophys. Acta. 1482:259-271. http://dx.doi.org/10.1016/S0167-4838(00)00161-8
56. Urade, Y., M. Ujihara, Y. Horiguchi, M. Igarashi, A. Nagata, K. Ikai, and O. Hayaishi. 1990. Mast cells contain spleen-type prostaglandin D synthetase. J. Biol. Chem. 265:371-375.
57. Vaniotis, G., B.G. Allen, and T.E. Hébert. 2011. Nuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signaling. Am. J. Physiol. Heart Circ. Physiol. 301:H1754-H1764. http://dx.doi.org/10.1152/ajpheart.00657.2011
58. Vassart, G., and S. Costagliola. 2011. G protein-coupled receptors: mutations and endocrine diseases. Nat. Rev. Endocrinol. 7:362-372. http://dx.doi.org/10.1038/nrendo.2011.20
59. Wang, X., J.S. Pattison, and H. Su. 2013. Posttranslational modification and quality control. Circ. Res. 112:367-381. http://dx.doi.org/10.1161/CIRCRESAHA.112.268706
60. Wu, B., P. Li, Y. Liu, Z. Lou, Y. Ding, C. Shu, S. Ye, M. Bartlam, B. Shen, and Z. Rao. 2004. 3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex. Proc. Natl. Acad. Sci. USA. 101:8348-8353. http://dx.doi.org/10.1073/pnas.0305969101
61. Zhao, R., and W.A. Houry. 2007. Molecular interaction network of the Hsp90 chaperone system. Adv. Exp. Med. Biol. 594:27-36. http://dx.doi.org/10.1007/978-0-387-39975-1_3
62. Zhou, Y., N. Shaw, Y. Li, Y. Zhao, R. Zhang, and Z.J. Liu. 2010. Structure-function analysis of human l-prostaglandin D synthase bound with fatty acid molecules. FASEB J. 24:4668-4677. http://dx.doi.org/10.1096/fj.10-164863
63. Zhu, T., F. Gobeil, A. Vazquez-Tello, M. Leduc, L. Rihakova, M. Bossolasco, G. Bkaily, K. Peri, D.R. Varma, R. Orvoine, and S. Chemtob. 2006. Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors. Can. J. Physiol. Pharmacol. 84:377-391. http://dx.doi.org/10.1139/y05-147
64. Zuiderweg, E.R., E.B. Bertelsen, A. Rousaki, M.P. Mayer, J.E. Gestwicki, and A. Ahmad. 2013. Allostery in the Hsp70 chaperone proteins. Top. Curr. Chem. 328:99-153. http://dx.doi.org/10.1007/128_2012_323